Search results
Showing 3211 to 3225 of 8314 results
Tests in secondary care to identify people at high risk of ovarian cancer (HTG453)
Evidence-based recommendations on tests in secondary care to identify people at high risk of ovarian cancer. The tests are the IOTA ADNEX model, Overa (MIA2G), RMI I (at thresholds other than 250), ROMA and IOTA Simple Rules.
Home News Articles {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"/"
Home News...
Membership details, terms of reference, future meeting dates and past meeting minutes for our 4 technology appraisal committees.
Home Freedom of information...
Evidence-based recommendations on ceftazidime with avibactam for treating severe drug-resistant gram-negative bacterial infections.
View recommendations for AMR1Show all sections
Cefiderocol for treating severe drug-resistant gram-negative bacterial infections (AMR2)
Evidence-based recommendations on cefiderocol for treating severe drug-resistant gram-negative bacterial infections.
See a complete list of all our guidance and quality standards currently open for consultation
Home What NICE does Our research work HTA Lab...
Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.
Our methods and processes (health technology evaluation manual)
NICE's technology appraisal and highly specialised technologies guidance manual
Dementia. Patient decision aid on enteral (tube) feeding for people living with severe dementia
Decision aid for Dementia: assessment, management and support for people living with dementia and their carers c NICE 2018. All rights reserved....
Advises NICE on the formulation of its guidance on the safety and efficacy of interventional procedures.
Read biographies of the members of our quality standards advisory committee.
This manual explains the processes and methods used to develop and update NICE guidelines, the guidance that NICE develops covering topics across clinical care (in primary, secondary and community care settings), social care and public health. For more information on the other types of NICE guidance and advice (including technology appraisal guidance), see about NICE